Astellas Pharma joined PPMD for a webinar on May 19, 2021 to provide an update on the company’s ASP0367 development program. Research & Clinical Trial Webinars,Webinars 3 years ago You may also like 1:04:24 Webinar: Viltepso – A Treatment Option for Patients Amenable to Exon 53 Skipping (April 22, 2021) 4 years ago Research & Clinical Trial Webinars,Webinars 1:00:42 Webinar: Gene Therapy – Turning Obstacles into Possibilities (April 20, 2021) 4 years ago Research & Clinical Trial Webinars,Webinars 1:09:32 PAAC Chats: Gaming and Disability (March 2021) 4 years ago For Teens & Adults,PPMD Adult Advisory Committee (PAAC) Webinars,Webinars 58:48 Webinar: Transforming the Treatment Paradigm with Dyne Therapeutics (March 31, 2021) 4 years ago Research & Clinical Trial Webinars,Webinars 56:15 Webinar: Santhera Pharmaceuticals Duchenne Drug Development Update (March 24, 2021) 4 years ago Research & Clinical Trial Webinars,Webinars 1:10:10 Webinar: Solid Biosciences Presents Safety & Efficacy Update (March 16, 2021) 4 years ago Research & Clinical Trial Webinars,Webinars 42:08 Assessing the Risk of Arrhythmias and Sudden Cardiac Events in Duchenne (March 4, 2021) 4 years ago Research & Clinical Trial Webinars,Webinars 50:55 Weekend Steroids and Exercise for Duchenne (March 3, 2021) 4 years ago Research & Clinical Trial Webinars,Webinars «1…678910…25»Page 8 of 25
by: Parent Project Muscular Dystrophy
